Virtu Financial LLC Cor Medix Inc. Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	SELL	$2.94 - $4.24 $48,751 - $70,307	-16,582 Reduced 60.56%	10,797 $46,000
Q4 2023 Feb 26, 2024	BUY	$3.0 - $4.01 $82,137 - $109,789	27,379 New	27,379 $103,000
Q2 2022 Aug 09, 2022	SELL	$2.73 - $5.61 $63,761 - $131,027	-23,356 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$3.83 - $6.24 $89,453 - $145,741	23,356 New	23,356 $128,000
Q3 2021 Nov 12, 2021	SELL	$4.46 - $7.11 $67,702 - $107,929	-15,180 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$6.05 - $10.09 $91,839 - $153,166	15,180 New	15,180 $104,000
Q1 2021 May 19, 2021	SELL	$6.84 - $17.58 $234,133 - $601,763	-34,230 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$5.0 - $9.15 $171,150 - $313,204	34,230 New	34,230 $254,000
Q4 2019 Feb 04, 2020	SELL	$4.96 - $7.75 $234,563 - $366,505	-47,291 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$6.38 - $9.69 $301,716 - $458,249	47,291 New	47,291 $302,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.